carlo-avolio
Carlo Avolio, MD
Associate Professor of Neurology

Education

1980 High School (Liceo Classico) Diploma, Bari, Italy 
1986 Medical School Degree, University of Bari, Italy
1990 Residency Diploma in Neurology, University of Bari, Italy

Biography

 

Research Interest

  • Neuroimmunology
  • Clinical Neurology

Scientific Activities

Participation in Scientific Societies
  • 1991 to date: Member to the Italian Society of Neurology (SIN)
  • 1991 to date: Member to the American Academy of Neurology (AAN)
  • 1998 to date: Member to the Italian Association of Neuroimmunology (AINI)
  • 1998 to date: Member to the International Society of Neuroimmunology (ISNI)
Participation in Board of Scientific Societies
  • 2004 to 2016: Member to the Board of the Italian Association of Neuroimmunology (AINI).
  • 2009 to 2016: Secretary/Treasure to the Italian Association of Neuroimmunology (AINI).

Publications

  1. Melchionda, D; Martino, T; Carapelle, E; Lalla, A; Cologno, D; Avolio, C (2017)  Wernicke's encephalopathy following reduced food intake due to depressive disorders.
  2. Iaffaldano, P; Simone, M; Lucisano, G; Ghezzi, A; Rabbit, G; Brescia Morra, et al. (2017) Prognostic indicators in pediatric clinically isolated syndrome.
  3. Martino, T; Melchionda, D; Tonti, P; De Francesco, V; Lalla, A; Mirror, Lm; Avolio, C. (2016) Weight loss and decubitus duodenal ulcer in Parkinson's disease treated with levodopa-carbidopa intestinal gel infusion.
  4. Caragnano M, Tortorella P, Bergami A, Ruggieri M, Livrea P, Mirror LM, Martino G, Trojano M, Furlan R, Avolio C (2012)  Monocytes P2X7 purinergic receptor is also modulated by glatiramer acetate in multiple sclerosis.
  5. TROJANO M; C. AVOLIO; DE ROBERTIS F; MANZARI C; ROSED A; LIVREA P (1989) Usefulness of a standardized method for collecting anamnestic data in multiple sclerosis (MS).
  6. Free DD, Mitri DD, Bergami A, Centonze D, Gasperini C, et al. (2011)  T regulatory cells are markers of disease activity in multiple sclerosis patients.
  7. Avolio, C; Caragnano, M; Tortorella, P; Ruggieri, M.; Grasso R, et al. (2011) P2X7 purinergic receptor on monocytes of patients with multiple sclerosis: effects of Glatiramer Acetate immune modulation.
  8. TROJANO M; PELLEGRINI F; PAOLICELLI D; FUIANI A; GB ZIMATORE; TORTORELLA C; SIMONE IL; PATTI F, et al. (2009) Post-marketing of disease modifying drugs in multiple sclerosis: An exploratory analysis of gender effects in interferon beta treatment.
  9. ROJANO M; PELLEGRINI F; PAOLICELLI D; FUIANI A; GB ZIMATORE, et al. (2009) Real-life impact of early interferon-beta therapy in relapsing multiple sclerosis.
  10. C. AVOLIO; FILIPPI M; TORTORELLA C; ROCCA MA; RUGGIERI M, et al. (2005) Serum MMP-9 / TIMP-1 and MMP-2 / TIMP-2 ratios in Multiple Sclerosis: Relationships with different MRIs of disease activity during IFN-beta-1a treatment.
  11. C. AVOLIO; RUGGIERI M; GIULIANI M; LIUZZI GM; LEANTE R, et al. ( 2003)  Serum MMP-2 and MMP-9 are elevated in different Multiple Sclerosis subtypes.
  12. LAMPASONA V; RIO J; FRANCIOTTA D; FURLAN R; C. AVOLIO et al. (2003) Serial immunoprecipitation assays for interferon- (IFN) -beta antibodies in multiple sclerosis patients.
  13. TROJANO M; LIGUORI M; PAOLICELLI D; GB ZIMATORE; DE ROBERTIS F, et al. (2003) Interferon beta in relapsing / remitting multiple sclerosis: an independent postmarketing study in southern Italy.
  14. AMATO MP; GRIMAUD J; ACHITI I; BARTOLOZZI ML; ADELEINE P (2004) European Validation of a Standardized Clinical Description of Multiple Sclerosis.
  15. Socket S; Petruzella V; Prascina F; Artuso L; Pacillo F, et al. (2010) Late-onset Leber's hereditary optic neuropathy mimiking Susac's syndrome
  16. Gori F, Mulinacci B, Massai L, Avolio C, Caragnano M, et al. (2011) IgG and IgM antibodies to the refolded MOG (1-125) extracellular domain in humans.
  17. Carapelle, E; Serra, L; Modoni, S; Falcone, M; Caltagirone, C, et al. (2017) How the cognitive reserve interacts with β-amyloid deposition in mitigating FDG metabolism: An observational study.
  18. RUGGIERI M; C. AVOLIO; SCACCO S; PICA C; LIA A; GB ZIMATORE, et al. (2006) Glatiramer Acetate induces pro-apoptotic mechanisms involving Bcl-2, Bax and Cyt-c in peripheral lymphocytes from multiple sclerosis patients.
  19. TROJANO M; C. AVOLIO (2009) Epstein-Barr virus (EBV) and multiple sclerosis association: EBV has a primary or secondary role?
  20. FRANCIOTTA D; C. AVOLIO; LOLLI F (2005)  Between-laboratory variability in oligoclonal IgG band numbering
  21. C. AVOLIO; GIULIANI F; LIUZZI GM; RUGGIERI M; PAOLICELLI D, et al. (2003)  Adhesion molecules and matrix metalloproteinases in MS: effects induced by Interferon beta.

neurology-flyer